EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access

Investigation of Mother-to-Child Transmission of Hepatitis B in Yinchuan, China: Cross-Sectional Survey Study

Jie Gu iD, Yiyuan Xu iD, Jiao Yuan iD, Yuxiang Chen iD, Jingxia Luo iD, Cui Guo iD, Guanbin Zhang iD

JMIR Public Health and Surveillance · 2024

DOI: 10.2196/60021 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift JMIR Public Health and Surveillance, 2024. Verfasst von Jie Gu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Yinchuan Women and Children Healthcare Hospital, Yinchun, China. Hauptthemen laut MEDLINE: Infectious Disease Transmission, Vertical, Hepatitis B. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatitis B poses a significant global public health challenge, with mother-to-child transmission (MTCT) being the primary method of hepatitis B virus (HBV) transmission. The prevalence of HBV infection in China is the highest in Asia, and it carries the greatest burden globally.

Objective

This study aims to critically evaluate the existing local strategies for preventing MTCT and the proposed potential enhancements by analyzing the prevalence of hepatitis B among pregnant women and their neonates in Yinchuan.

Methods

From January 2017 to December 2021, 37,557 prenatal screening records were collected. Among them, 947 pregnant women who tested positive for hepatitis B surface antigen (HBsAg) near delivery and their 960 neonates were included in an HBV-exposed group, while 29 pregnant women who tested negative and their 30 neonates were included in an HBV-nonexposed group. HBV markers in maternal peripheral blood and neonatal cord blood were analyzed using the least absolute shrinkage and selection operator (LASSO) regression, logistic regression, chi-square test, t-test, and U-test. Additionally, to further evaluate the diagnostic value of HBsAg positivity in cord blood, we conducted an additional follow-up study on 103 infants who tested positive for HBsAg in their cord blood.

Results

The prevalence of HBV among pregnant women was 2.5% (947/37,557), with a declining trend every year (χ²4=19.7; P=.001). From 2018 to 2020, only 33.0% (35/106) of eligible pregnant women received antiviral medication treatment. Using LASSO regression to screen risk factors correlated with HBsAg positivity in cord blood (when log [λ] reached a minimum value of –5.02), 5 variables with nonzero coefficients were selected, including maternal hepatitis B e-antigen (HBeAg) status, maternal hepatitis B core antibody (HBcAb) status, maternal HBV DNA load, delivery method, and neonatal birth weight. Through univariate and multivariate logistic regression, delivery by cesarean section (adjusted odds ratio [aOR] 0.52, 95% CI 0.31-0.87), maternal HBeAg positivity (aOR 2.05, 95% CI 1.27-3.33), low maternal viral load (aOR 2.69, 95% CI 1.33-5.46), and high maternal viral load (aOR 2.69, 95% CI 1.32-5.51) were found to be strongly associated with cord blood HBsAg positivity. In the additional follow-up study, 61 infants successfully completed the follow-up, and only 2 were found to be infected with HBV. The mothers of both these infants had detectable HBV DNA levels and should have received standard antiviral therapy. The results of the hepatitis B surface antibody (HBsAb) positivity rate and titer test indicated a gradual decline in the immunity of vaccinated infants as the interval after vaccination increased.

Conclusions

The clinical relevance of HBV marker detection in cord blood is restricted within the current prevention measures for MTCT. There is an emphasis on the significance of public education regarding hepatitis B and the reinforcement of postnatal follow-up for the prevention of MTCT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Infectious Disease Transmission, VerticalHepatitis BHumansFemaleChinaPregnancyCross-Sectional StudiesAdultInfant, NewbornPrevalencePregnancy Complications, InfectiousHepatitis B Surface Antigens

Stichwörter der Autor:innen

antiviral therapycord bloodhepatitis B virusimmunization failuremother-to-child transmission

Substanzen

Hepatitis B Surface Antigens

Autor:innen und Institutionen

  • Department of Neonatology, Yinchuan Women and Children Healthcare Hospital, Yinchun, China.
  • Fujian CapitalBio Medical Laboratory, Fuzhou, China.
  • Beijing Ganjiang Biotechnology, Beijing, China.
  • Department of Laboratory Medicine, Fujian Medical University, Fuzhou, China.
  • Institute of Precision Medicine, Fujian Medical University, Fuzhou, China.

ORCID-Profile: Jie Gu, Yiyuan Xu, Jiao Yuan, Yuxiang Chen, Jingxia Luo, Cui Guo, Guanbin Zhang

Zitieren

APA

Gu, J., Xu, Y., Yuan, J., Chen, Y., Luo, J., Guo, C., & Zhang, G. (2024). Investigation of Mother-to-Child Transmission of Hepatitis B in Yinchuan, China: Cross-Sectional Survey Study. JMIR Public Health and Surveillance. https://doi.org/10.2196/60021

Vancouver

Gu J, Xu Y, Yuan J, Chen Y, Luo J, Guo C, et al. Investigation of Mother-to-Child Transmission of Hepatitis B in Yinchuan, China: Cross-Sectional Survey Study. JMIR Public Health and Surveillance. 2024. doi:10.2196/60021

BibTeX
@article{Gu2024,
  author = {Gu, Jie and Xu, Yiyuan and Yuan, Jiao and Chen, Yuxiang and Luo, Jingxia and Guo, Cui and Zhang, Guanbin},
  title = {Investigation of Mother-to-Child Transmission of Hepatitis B in Yinchuan, China: Cross-Sectional Survey Study},
  journal = {JMIR Public Health and Surveillance},
  year = {2024},
  doi = {10.2196/60021}
}
Kostenlos starten →